94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Hongliang Gao1,2,3†
Jing Wu1†
Zhenyu Sun4†Furong Zhang1Tianshu Shi5
Ke Lu6
Dongfu Qian4Zicheng Yin7
Yinjuan Zhao3*Jian Qin1*
Bin Xue1*- 1Core Laboratory, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China
- 2School of Clinical Medicine, Wannan Medical College, Wuhu, China
- 3Collaborative Innovation Center of Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing, China
- 4School of Health Policy and Management, Center for Global Health, Nanjing Medical University, Nanjing, China
- 5State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
- 6Research Center for Computer-Aided Drug Discovery, Chinese Academy of Sciences, Shenzhen, China
- 7Nanjing Foreign Language School, Nanjing, China
A Corrigendum on
Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis
by Gao H, Wu J, Sun Z, Zhang F, Shi T, Lu K, Qian D, Yin Z, Zhao Y, Qin J and Xue B (2022), .Front. Pharmacol. 13:1062249. doi: 10.3389/fphar.2022.1062249
In the published article, there was an error in the Funding statement. The funding statement for the National Natural Science Foundation of China was displayed as “32071145”.
The correct statement is “the National Natural Science Foundation of China, 32071142, 32271187.’’
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: lecithin cholesterol acyltransferase, physiological, emerging trends, risk, bibliometrics
Citation: Gao H, Wu J, Sun Z, Zhang F, Shi T, Lu K, Qian D, Yin Z, Zhao Y, Qin J and Xue B (2023) Corrigendum: Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis. Front. Pharmacol. 13:1133686. doi: 10.3389/fphar.2022.1133686
Received: 29 December 2022; Accepted: 30 December 2022;
Published: 12 January 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Gao, Wu, Sun, Zhang, Shi, Lu, Qian, Yin, Zhao, Qin and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yinjuan Zhao, emhhb3lpbmp1YW5AbmpmdS5lZHUuY24=; Jian Qin, cWluamlhbkBuam11LmVkdS5jbg==; Bin Xue, eHVlYmluQG5qbXUuZWR1LmNu
†These authors have contributed equally to this work